Venture • Life Science

Andera Partners Invests In Enyo Pharma

On June 4, 2018, private equity firm Andera Partners invested in life science company Enyo Pharma

Investment Context
  • This is Andera Partners’ 15th transaction in the Life Science sector.
  • This is Andera Partners’ 44th transaction in France.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date June 4, 2018
Target Enyo Pharma
Sector Life Science
Investor(s) Andera Partners
Deal Type Venture

Target Company

Enyo Pharma

Lyon, France
Enyo Pharma is a clinical‑stage biopharmaceutical company advancing small‑molecule therapeutics to treat kidney and liver diseases. Enyo Pharma was founded in 2014 and is based in Lyon, France.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Andera Partners

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 3.7B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.


Deal Context for Investor #
Overall 63 of 123
Sector: Life Science 15 of 27
Type: Venture 15 of 28
Country: France 44 of 86
Year: 2018 5 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-06-04 TRiCares

Paris, France

TRiCares is a medical-device company developing a minimally invasive, catheter-delivered tricuspid valve replacement system for patients with severe tricuspid regurgitation. Its transfemoral system Topaz aims to enable valve replacement without open-heart surgery. TRiCares was founded in 2013 and is based in Paris, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-06-19 Geotec

Quetigny, France

Geotec is a geotechnical and environmental engineering design office which advises all the interlocutors of the act of construction: Owners, Project Managers, Companies, Control Offices, Experts. Geotec was founded in 1973 and is based in Quetigny, France.

Sell -

Explore Related M&A Activity